A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
Amgen has created a number of websites to better serve you with specific questions.
For the past 40 years, Amgen has been committed to serving the needs of patients. And this October, we are looking at women’s health and the many concerns that can disrupt and detract from quality of life, such as breast cancer, menopause and osteoporosis.
At Amgen, we are dedicated to the relentless pursuit of breakthroughs for cancer patients and their families. We want to revolutionize the way cancer patients are diagnosed, treated, and cared for. Helping them know the signs and symptoms of breast cancer is just the first step in Amgen’s dedication to women's health. As a leader in oncology, we know breast cancer and understand that there are many common misconceptions around it. Uncover the truth about some common breast cancer myths.
Osteoporosis is a chronic condition that weakens bones and leaves people at risk of a fragility fracture; it is often described as a “silent” disease as symptoms may not present until a bone is broken. And menopause can lead to a loss of bone density, increasing the risk of a fragility fracture. Fragility fractures can be life-changing events, resulting in pain, isolation and even loss of independence. Every day across the EU, there are almost 10,000 fragility fractures – most of which occur in women over the age of 50. And worldwide, 1 in 3 women over the age of 50 will suffer a fracture due to osteoporosis.
In order to ensure change from a policy perspective, Amgen has created an Osteoporosis and Fragility Fractures Policy Toolkit in order to drive the policy changes needed to ensure that best-practice care is available to the millions of osteoporosis patients in Europe. This way they can avoid fractures and maintain their quality of life, mobility and independence.
Our three key policy aims are:
Menopause affects each woman differently, but there are some symptoms that many women will have in common. We want to make sure that women recognize the symptoms and talk to their doctor about them. In addition, we want to raise awareness about how the effects of menopause can be eased with simple lifestyle changes to lessen the impact on women’s lives.
Our commitment to women’s health goes beyond developing innovative treatment options. We are also leveraging our data, science, digital technology and external partnerships to help identify at-risk patients and find options that make these life-changing conditions more manageable. “Break and Fix” healthcare systems focus on reactively treating health events and disease, as opposed to preventing these events from happening in the first place. Amgen supports a “Predict & Prevent” mindset that enables healthcare professionals to proactively intervene early for appropriate patients.
To this end, Amgen has created disease awareness programs like #ProtectUrLife, which provides participants with access to health screenings, healthcare professionals and educational materials, so they are better prepared to protect their bones and heart.
Our teams continue to work tirelessly to ensure access to our treatments, so patients have more options on the table. To participate and help us raise awareness of these critical health concerns and the impact they have on women, visit our social media channels and check out this important campaign.
#WomenAreStrong